1 in 4 Patients With NSCLC Respond Poorly to COVID-19 Vaccine ...Middle East

Medscape - News
About 1 in 4 patients with non–small cell lung cancer have an unsatisfactory antibody response to the Omicron variant following COVID-19 vaccination, reports a new study. MDedge News

Hence then, the article about 1 in 4 patients with nsclc respond poorly to covid 19 vaccine was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( 1 in 4 Patients With NSCLC Respond Poorly to COVID-19 Vaccine )

Apple Storegoogle play

Last updated :

Also on site :